According to our recent payer coverage analysis for detoxification agents, combined with news from key healthcare influencers, market access is shifting in this drug landscape.
To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.
Payer Coverage: A look at market access over the past quarter reveals a slight increase in restricted lives across medicare and health exchange formularies. The largest shift is in the form of PAs and their increasingly restrictive nature.
Source: MMIT data as of Q2 2017
Trends: A recent article shows signs of prescriber push back when it comes to the "quantity limits" placed on the number of detox patients a single physician can have at any one time. Other articles, such as one regarding instances of detoxification agents being removed from Medicaid PDLs, support the increasing obstacles for prescribers.
To read the full Reality Check on detox agents with key findings on clinical characteristics, detoxification agent drug market access and payer coverage, please click on the button below: